FAILURE TO OBTAIN LONG-TERM PATENCY AFTER IMPLANTATION OF FIBROUS POLYURETHANE PROSTHESES IN THE CAROTID ARTERIES OF RABBITS

被引:6
作者
HESS, F
STEEGHS, S
JERUSALEM, C
BRAUN, B
GRANDE, P
机构
[1] Laboratory for Cell Biology and Histology, Catholic University of Nijmegen
[2] B. Braun Melsungen A.G, Melsungen
关键词
D O I
10.1002/micr.1920120304
中图分类号
R61 [外科手术学];
学科分类号
摘要
Fibrous polyurethane prostheses were implanted in the carotid arteries and aortae of New Zealand white (NZW) and Chinchilla (CHIN) rabbits. No immediate post-implantation patency was obtained after implantation in the carotid arteries in NZW rabbits. In CHIN rabbits patency up to 1 week was obtained after carotid implantation. Attempts to increase patency rates by administration of 20 mg/kg body weight/day of both dipyridamol (DIP) and acetyl-salicylic acid (ASA) p.o., starting the week before implantation, had an adverse effect; prostheses became occluded within a few hours after implantation. Coagulation tests (Lee and White, Am J Med Sci 145:495-503, 1913) carried out with blood drawn from CHIN rabbits revealed hypercoaguability after administration of either 10 or 20 mg/kg body weight/day of both DIP and ASA compared to pre-medication values. Prostheses implanted in the aortae of both strains remained patent without anti-platelet-aggregation therapy for a 3-month observation period. It is concluded that in the NZW rabbit carotid implantation was not successful due to severe spasmic reactions and that in CHIN rabbits only very short-term patency could be obtained both with and without administration of 10 or 20 mg/kg body weight/day medication DIP and ASA.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 14 条
[1]  
Branson DF, Picha GJ, Desprez J, Expanded polytetrafluoroethylene as a microvascular graft: a study of four fibril lengths, Plast Reconstr Surg, 76, pp. 754-763, (1985)
[2]  
Hess F, Jerusalem C, Braun B, Grande P, Three years experience with experimental implantation of fibrous polyurethane microvascular prostheses in the rat aorta, Microsurgery, 6, pp. 155-162, (1985)
[3]  
Ganske JG, Demuthg RJ, Miller SH, Buch DC, Dolph JL, Comparison of expanded polytetrafluoroethylene microvascular grafts to autogenous vein grafts, Plast Reconstr Surg, 70, pp. 193-201, (1982)
[4]  
Watanabe K, Microarterial prostheses of expanded polytetrafluoroethylene, J Microsurgery, 2, pp. 11-21, (1980)
[5]  
Nordestgaard AG, Buckels JAC, Wilson SE, A laboratory model for the evaluation of thromboembolic complications of small diameter vascular prostheses, Br J Exp Path, 67, pp. 839-849, (1986)
[6]  
Nordestgaard AG, Buchels JAC, Wilson SE, Platelet antagonists eliminate thromboembolic complications of small‐diameter polytetrafluoroethylene arterial prostheses, J Vasc Surg, 5, pp. 110-117, (1987)
[7]  
Nordestgaard AG, Wilson SE, Neoendothelialization of small‐diameter polytetrafluoroethylene arterial grafts is not delayed by aspirin and dipyridamol, J Vasc Surg, 7, pp. 93-98, (1988)
[8]  
Hess F, Steeghs S, Jerusalem C, Wijn P, Skotnicki S, Determination of the patency of vascular prostheses implanted in the rat aorta by means of ultrasonic bloodflow measurements, Microsurgery, 8, pp. 5-10, (1987)
[9]  
Hess F, Jerusalem C, Braun B, Grande P, Patency and neointima development in 10 cm long microvascular polyurethane prostheses implanted into the rat aorta, Thoracic Cardiovasc Surg, 32, pp. 283-287, (1984)
[10]  
Braun B, Grande P, Lehnhardt F, Jerusalem C, Hess F, (1988)